nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CYP3A5—Disulfiram—alcohol dependence	0.0865	0.198	CbGbCtD
Imatinib—ABCB1—Naltrexone—alcohol dependence	0.0606	0.139	CbGbCtD
Imatinib—CYP2C9—Disulfiram—alcohol dependence	0.058	0.133	CbGbCtD
Imatinib—CYP2C19—Citalopram—alcohol dependence	0.0497	0.114	CbGbCtD
Imatinib—CYP1A2—Citalopram—alcohol dependence	0.0459	0.105	CbGbCtD
Imatinib—ABCB1—Citalopram—alcohol dependence	0.0401	0.0919	CbGbCtD
Imatinib—CYP2D6—Citalopram—alcohol dependence	0.0378	0.0866	CbGbCtD
Imatinib—CYP3A4—Disulfiram—alcohol dependence	0.0337	0.0773	CbGbCtD
Imatinib—CYP3A4—Citalopram—alcohol dependence	0.024	0.0551	CbGbCtD
Imatinib—PIP4K2C—pancreas—alcohol dependence	0.000989	0.00657	CbGeAlD
Imatinib—CA3—cardiovascular system—alcohol dependence	0.000971	0.00645	CbGeAlD
Imatinib—PIP4K2C—gonad—alcohol dependence	0.000923	0.00613	CbGeAlD
Imatinib—NQO2—brainstem—alcohol dependence	0.000916	0.00608	CbGeAlD
Imatinib—HIPK4—brain—alcohol dependence	0.000886	0.00589	CbGeAlD
Imatinib—PDGFRA—forebrain—alcohol dependence	0.000881	0.00585	CbGeAlD
Imatinib—CA7—digestive system—alcohol dependence	0.000879	0.00584	CbGeAlD
Imatinib—ABCA3—brain—alcohol dependence	0.000876	0.00582	CbGeAlD
Imatinib—ABL2—blood—alcohol dependence	0.00085	0.00565	CbGeAlD
Imatinib—CA7—midbrain—alcohol dependence	0.000827	0.00549	CbGeAlD
Imatinib—NQO2—adrenal cortex—alcohol dependence	0.000819	0.00544	CbGeAlD
Imatinib—CA12—forebrain—alcohol dependence	0.000814	0.0054	CbGeAlD
Imatinib—DDR1—brain—alcohol dependence	0.000809	0.00537	CbGeAlD
Imatinib—PIP4K2C—blood—alcohol dependence	0.000805	0.00534	CbGeAlD
Imatinib—PIP4K2C—midbrain—alcohol dependence	0.000794	0.00528	CbGeAlD
Imatinib—CSF1R—forebrain—alcohol dependence	0.000776	0.00515	CbGeAlD
Imatinib—CA9—digestive system—alcohol dependence	0.000772	0.00513	CbGeAlD
Imatinib—PDGFRA—cardiovascular system—alcohol dependence	0.000745	0.00495	CbGeAlD
Imatinib—SLC47A1—brainstem—alcohol dependence	0.000734	0.00488	CbGeAlD
Imatinib—KIT—brainstem—alcohol dependence	0.00073	0.00485	CbGeAlD
Imatinib—NQO2—pancreas—alcohol dependence	0.000726	0.00482	CbGeAlD
Imatinib—CSF1R—adrenal cortex—alcohol dependence	0.000719	0.00478	CbGeAlD
Imatinib—LCK—blood—alcohol dependence	0.000714	0.00474	CbGeAlD
Imatinib—ABL2—testis—alcohol dependence	0.000703	0.00467	CbGeAlD
Imatinib—PIP4K2C—endocrine gland—alcohol dependence	0.000698	0.00464	CbGeAlD
Imatinib—CA14—midbrain—alcohol dependence	0.000689	0.00458	CbGeAlD
Imatinib—PDGFRA—gonad—alcohol dependence	0.000676	0.00449	CbGeAlD
Imatinib—CA3—endocrine gland—alcohol dependence	0.000666	0.00443	CbGeAlD
Imatinib—PIP4K2C—testis—alcohol dependence	0.000665	0.00442	CbGeAlD
Imatinib—ABL2—liver—alcohol dependence	0.000665	0.00442	CbGeAlD
Imatinib—SLC47A1—adrenal cortex—alcohol dependence	0.000657	0.00436	CbGeAlD
Imatinib—CSF1R—cardiovascular system—alcohol dependence	0.000656	0.00436	CbGeAlD
Imatinib—PIP4K2C—nervous system—alcohol dependence	0.000653	0.00434	CbGeAlD
Imatinib—ABL2—cerebellum—alcohol dependence	0.00065	0.00431	CbGeAlD
Imatinib—CA1—forebrain—alcohol dependence	0.000644	0.00428	CbGeAlD
Imatinib—CA7—cerebellum—alcohol dependence	0.00064	0.00425	CbGeAlD
Imatinib—CA9—endocrine gland—alcohol dependence	0.000638	0.00424	CbGeAlD
Imatinib—PDGFRB—adrenal cortex—alcohol dependence	0.000638	0.00424	CbGeAlD
Imatinib—ABL1—brainstem—alcohol dependence	0.000636	0.00422	CbGeAlD
Imatinib—CA3—testis—alcohol dependence	0.000635	0.00422	CbGeAlD
Imatinib—PIP4K2C—liver—alcohol dependence	0.000629	0.00418	CbGeAlD
Imatinib—PIP4K2C—central nervous system—alcohol dependence	0.000629	0.00418	CbGeAlD
Imatinib—CA3—nervous system—alcohol dependence	0.000624	0.00414	CbGeAlD
Imatinib—PDGFRA—digestive system—alcohol dependence	0.000619	0.00411	CbGeAlD
Imatinib—PIP4K2C—cerebellum—alcohol dependence	0.000615	0.00408	CbGeAlD
Imatinib—CA9—testis—alcohol dependence	0.000608	0.00404	CbGeAlD
Imatinib—CA3—liver—alcohol dependence	0.000601	0.00399	CbGeAlD
Imatinib—CA3—central nervous system—alcohol dependence	0.0006	0.00399	CbGeAlD
Imatinib—KIT—cardiovascular system—alcohol dependence	0.000596	0.00396	CbGeAlD
Imatinib—CSF1R—gonad—alcohol dependence	0.000596	0.00396	CbGeAlD
Imatinib—CYP3A7—endocrine gland—alcohol dependence	0.000592	0.00393	CbGeAlD
Imatinib—SLC22A1—forebrain—alcohol dependence	0.000591	0.00393	CbGeAlD
Imatinib—NQO2—blood—alcohol dependence	0.000591	0.00393	CbGeAlD
Imatinib—LCK—testis—alcohol dependence	0.000591	0.00392	CbGeAlD
Imatinib—PDGFRA—blood—alcohol dependence	0.000589	0.00392	CbGeAlD
Imatinib—SLC22A2—digestive system—alcohol dependence	0.000588	0.0039	CbGeAlD
Imatinib—NQO2—midbrain—alcohol dependence	0.000583	0.00388	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—alcohol dependence	0.000582	0.00387	CbGeAlD
Imatinib—KIT—pancreas—alcohol dependence	0.000579	0.00385	CbGeAlD
Imatinib—CA12—digestive system—alcohol dependence	0.000571	0.00379	CbGeAlD
Imatinib—ABL1—adrenal cortex—alcohol dependence	0.000568	0.00378	CbGeAlD
Imatinib—PDGFRB—pancreas—alcohol dependence	0.000566	0.00376	CbGeAlD
Imatinib—CA9—cerebellum—alcohol dependence	0.000562	0.00373	CbGeAlD
Imatinib—LCK—liver—alcohol dependence	0.000558	0.00371	CbGeAlD
Imatinib—CA14—liver—alcohol dependence	0.000546	0.00362	CbGeAlD
Imatinib—CA1—cardiovascular system—alcohol dependence	0.000545	0.00362	CbGeAlD
Imatinib—CSF1R—digestive system—alcohol dependence	0.000545	0.00362	CbGeAlD
Imatinib—SLC47A1—gonad—alcohol dependence	0.000544	0.00361	CbGeAlD
Imatinib—KIT—gonad—alcohol dependence	0.000541	0.00359	CbGeAlD
Imatinib—CYP3A7—liver—alcohol dependence	0.000534	0.00354	CbGeAlD
Imatinib—CA14—cerebellum—alcohol dependence	0.000533	0.00354	CbGeAlD
Imatinib—CA1—pancreas—alcohol dependence	0.00053	0.00352	CbGeAlD
Imatinib—PDGFRB—gonad—alcohol dependence	0.000528	0.00351	CbGeAlD
Imatinib—ABL2—brain—alcohol dependence	0.000528	0.0035	CbGeAlD
Imatinib—CA7—brain—alcohol dependence	0.00052	0.00345	CbGeAlD
Imatinib—CSF1R—blood—alcohol dependence	0.000519	0.00345	CbGeAlD
Imatinib—ABL1—cardiovascular system—alcohol dependence	0.000519	0.00345	CbGeAlD
Imatinib—NQO2—endocrine gland—alcohol dependence	0.000512	0.0034	CbGeAlD
Imatinib—CSF1R—midbrain—alcohol dependence	0.000512	0.0034	CbGeAlD
Imatinib—PDGFRA—endocrine gland—alcohol dependence	0.000511	0.0034	CbGeAlD
Imatinib—ABL1—pancreas—alcohol dependence	0.000504	0.00335	CbGeAlD
Imatinib—PIP4K2C—brain—alcohol dependence	0.000499	0.00332	CbGeAlD
Imatinib—SLC47A1—digestive system—alcohol dependence	0.000497	0.0033	CbGeAlD
Imatinib—KIT—digestive system—alcohol dependence	0.000495	0.00329	CbGeAlD
Imatinib—NQO2—testis—alcohol dependence	0.000489	0.00325	CbGeAlD
Imatinib—PDGFRA—testis—alcohol dependence	0.000488	0.00324	CbGeAlD
Imatinib—PDGFRB—digestive system—alcohol dependence	0.000483	0.00321	CbGeAlD
Imatinib—NQO2—nervous system—alcohol dependence	0.00048	0.00319	CbGeAlD
Imatinib—PDGFRA—nervous system—alcohol dependence	0.000478	0.00318	CbGeAlD
Imatinib—CA3—brain—alcohol dependence	0.000477	0.00317	CbGeAlD
Imatinib—SLC47A1—blood—alcohol dependence	0.000474	0.00315	CbGeAlD
Imatinib—CA12—endocrine gland—alcohol dependence	0.000472	0.00313	CbGeAlD
Imatinib—KIT—blood—alcohol dependence	0.000471	0.00313	CbGeAlD
Imatinib—ABL1—gonad—alcohol dependence	0.000471	0.00313	CbGeAlD
Imatinib—KIT—midbrain—alcohol dependence	0.000465	0.00309	CbGeAlD
Imatinib—NQO2—liver—alcohol dependence	0.000462	0.00307	CbGeAlD
Imatinib—NQO2—central nervous system—alcohol dependence	0.000462	0.00307	CbGeAlD
Imatinib—PDGFRA—liver—alcohol dependence	0.000461	0.00306	CbGeAlD
Imatinib—PDGFRA—central nervous system—alcohol dependence	0.000461	0.00306	CbGeAlD
Imatinib—PDGFRB—blood—alcohol dependence	0.00046	0.00306	CbGeAlD
Imatinib—PDGFRB—midbrain—alcohol dependence	0.000454	0.00302	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—alcohol dependence	0.000454	0.00301	CbGeAlD
Imatinib—CA1—digestive system—alcohol dependence	0.000452	0.003	CbGeAlD
Imatinib—NQO2—cerebellum—alcohol dependence	0.000451	0.003	CbGeAlD
Imatinib—PDGFRA—cerebellum—alcohol dependence	0.00045	0.00299	CbGeAlD
Imatinib—CSF1R—endocrine gland—alcohol dependence	0.00045	0.00299	CbGeAlD
Imatinib—CA12—nervous system—alcohol dependence	0.000442	0.00293	CbGeAlD
Imatinib—CA14—brain—alcohol dependence	0.000433	0.00288	CbGeAlD
Imatinib—CA2—brainstem—alcohol dependence	0.000433	0.00287	CbGeAlD
Imatinib—ORM1—blood—alcohol dependence	0.000432	0.00287	CbGeAlD
Imatinib—CA1—blood—alcohol dependence	0.000431	0.00286	CbGeAlD
Imatinib—ABL1—digestive system—alcohol dependence	0.000431	0.00286	CbGeAlD
Imatinib—CSF1R—testis—alcohol dependence	0.000429	0.00285	CbGeAlD
Imatinib—CA12—central nervous system—alcohol dependence	0.000425	0.00282	CbGeAlD
Imatinib—CSF1R—nervous system—alcohol dependence	0.000421	0.0028	CbGeAlD
Imatinib—CA2—forebrain—alcohol dependence	0.000418	0.00277	CbGeAlD
Imatinib—SLC47A1—endocrine gland—alcohol dependence	0.000411	0.00273	CbGeAlD
Imatinib—ABL1—blood—alcohol dependence	0.00041	0.00272	CbGeAlD
Imatinib—KIT—endocrine gland—alcohol dependence	0.000409	0.00271	CbGeAlD
Imatinib—CSF1R—liver—alcohol dependence	0.000406	0.0027	CbGeAlD
Imatinib—CSF1R—central nervous system—alcohol dependence	0.000406	0.00269	CbGeAlD
Imatinib—ABL1—midbrain—alcohol dependence	0.000405	0.00269	CbGeAlD
Imatinib—Muscle spasms—Acamprosate—alcohol dependence	0.000402	0.00145	CcSEcCtD
Imatinib—Face oedema—Citalopram—alcohol dependence	0.000402	0.00144	CcSEcCtD
Imatinib—Alopecia—Naltrexone—alcohol dependence	0.000402	0.00144	CcSEcCtD
Imatinib—PDGFRB—endocrine gland—alcohol dependence	0.000399	0.00265	CbGeAlD
Imatinib—Mental disorder—Naltrexone—alcohol dependence	0.000399	0.00143	CcSEcCtD
Imatinib—CSF1R—cerebellum—alcohol dependence	0.000396	0.00263	CbGeAlD
Imatinib—Cardiac arrest—Citalopram—alcohol dependence	0.000396	0.00142	CcSEcCtD
Imatinib—Malnutrition—Naltrexone—alcohol dependence	0.000396	0.00142	CcSEcCtD
Imatinib—SLC22A1—blood—alcohol dependence	0.000395	0.00263	CbGeAlD
Imatinib—Tremor—Acamprosate—alcohol dependence	0.000392	0.00141	CcSEcCtD
Imatinib—SLC47A1—testis—alcohol dependence	0.000392	0.0026	CbGeAlD
Imatinib—Flatulence—Naltrexone—alcohol dependence	0.00039	0.0014	CcSEcCtD
Imatinib—KIT—testis—alcohol dependence	0.00039	0.00259	CbGeAlD
Imatinib—Ill-defined disorder—Acamprosate—alcohol dependence	0.000388	0.00139	CcSEcCtD
Imatinib—Dysgeusia—Naltrexone—alcohol dependence	0.000388	0.00139	CcSEcCtD
Imatinib—Dehydration—Citalopram—alcohol dependence	0.000387	0.00139	CcSEcCtD
Imatinib—CA2—adrenal cortex—alcohol dependence	0.000387	0.00257	CbGeAlD
Imatinib—Anaemia—Acamprosate—alcohol dependence	0.000387	0.00139	CcSEcCtD
Imatinib—SLC47A1—nervous system—alcohol dependence	0.000385	0.00256	CbGeAlD
Imatinib—Back pain—Naltrexone—alcohol dependence	0.000383	0.00138	CcSEcCtD
Imatinib—KIT—nervous system—alcohol dependence	0.000383	0.00254	CbGeAlD
Imatinib—Angioedema—Acamprosate—alcohol dependence	0.000382	0.00137	CcSEcCtD
Imatinib—Dry skin—Citalopram—alcohol dependence	0.000382	0.00137	CcSEcCtD
Imatinib—Muscle spasms—Naltrexone—alcohol dependence	0.000381	0.00137	CcSEcCtD
Imatinib—PDGFRB—testis—alcohol dependence	0.000381	0.00253	CbGeAlD
Imatinib—Abdominal pain upper—Citalopram—alcohol dependence	0.000381	0.00137	CcSEcCtD
Imatinib—Hypokalaemia—Citalopram—alcohol dependence	0.000379	0.00136	CcSEcCtD
Imatinib—Malaise—Acamprosate—alcohol dependence	0.000377	0.00136	CcSEcCtD
Imatinib—Breast disorder—Citalopram—alcohol dependence	0.000376	0.00135	CcSEcCtD
Imatinib—Vertigo—Acamprosate—alcohol dependence	0.000376	0.00135	CcSEcCtD
Imatinib—Syncope—Acamprosate—alcohol dependence	0.000375	0.00135	CcSEcCtD
Imatinib—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000375	0.00135	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000375	0.00135	CcSEcCtD
Imatinib—Cramp muscle—Citalopram—alcohol dependence	0.000375	0.00135	CcSEcCtD
Imatinib—Leukopenia—Acamprosate—alcohol dependence	0.000375	0.00135	CcSEcCtD
Imatinib—ORM1—endocrine gland—alcohol dependence	0.000374	0.00249	CbGeAlD
Imatinib—CA1—endocrine gland—alcohol dependence	0.000374	0.00248	CbGeAlD
Imatinib—PDGFRB—nervous system—alcohol dependence	0.000374	0.00248	CbGeAlD
Imatinib—Vision blurred—Naltrexone—alcohol dependence	0.000373	0.00134	CcSEcCtD
Imatinib—Nasopharyngitis—Citalopram—alcohol dependence	0.000373	0.00134	CcSEcCtD
Imatinib—Tremor—Naltrexone—alcohol dependence	0.000371	0.00133	CcSEcCtD
Imatinib—SLC47A1—liver—alcohol dependence	0.000371	0.00246	CbGeAlD
Imatinib—SLC47A1—central nervous system—alcohol dependence	0.00037	0.00246	CbGeAlD
Imatinib—Palpitations—Acamprosate—alcohol dependence	0.00037	0.00133	CcSEcCtD
Imatinib—Gastritis—Citalopram—alcohol dependence	0.000369	0.00132	CcSEcCtD
Imatinib—KIT—liver—alcohol dependence	0.000368	0.00245	CbGeAlD
Imatinib—KIT—central nervous system—alcohol dependence	0.000368	0.00245	CbGeAlD
Imatinib—Loss of consciousness—Acamprosate—alcohol dependence	0.000368	0.00132	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000367	0.00132	CcSEcCtD
Imatinib—Muscular weakness—Citalopram—alcohol dependence	0.000367	0.00132	CcSEcCtD
Imatinib—Ill-defined disorder—Naltrexone—alcohol dependence	0.000367	0.00132	CcSEcCtD
Imatinib—NQO2—brain—alcohol dependence	0.000367	0.00244	CbGeAlD
Imatinib—PDGFRA—brain—alcohol dependence	0.000366	0.00243	CbGeAlD
Imatinib—Cough—Acamprosate—alcohol dependence	0.000365	0.00131	CcSEcCtD
Imatinib—Convulsion—Acamprosate—alcohol dependence	0.000363	0.0013	CcSEcCtD
Imatinib—Abdominal distension—Citalopram—alcohol dependence	0.000363	0.0013	CcSEcCtD
Imatinib—SLC47A1—cerebellum—alcohol dependence	0.000362	0.0024	CbGeAlD
Imatinib—Angioedema—Naltrexone—alcohol dependence	0.000362	0.0013	CcSEcCtD
Imatinib—Hypertension—Acamprosate—alcohol dependence	0.000361	0.0013	CcSEcCtD
Imatinib—Influenza—Citalopram—alcohol dependence	0.00036	0.00129	CcSEcCtD
Imatinib—Dysphagia—Citalopram—alcohol dependence	0.00036	0.00129	CcSEcCtD
Imatinib—KIT—cerebellum—alcohol dependence	0.00036	0.00239	CbGeAlD
Imatinib—PDGFRB—liver—alcohol dependence	0.00036	0.00239	CbGeAlD
Imatinib—PDGFRB—central nervous system—alcohol dependence	0.00036	0.00239	CbGeAlD
Imatinib—ABCG2—adrenal cortex—alcohol dependence	0.000358	0.00238	CbGeAlD
Imatinib—Malaise—Naltrexone—alcohol dependence	0.000357	0.00128	CcSEcCtD
Imatinib—Eosinophilia—Citalopram—alcohol dependence	0.000357	0.00128	CcSEcCtD
Imatinib—Arthralgia—Acamprosate—alcohol dependence	0.000356	0.00128	CcSEcCtD
Imatinib—Chest pain—Acamprosate—alcohol dependence	0.000356	0.00128	CcSEcCtD
Imatinib—Myalgia—Acamprosate—alcohol dependence	0.000356	0.00128	CcSEcCtD
Imatinib—ABL1—endocrine gland—alcohol dependence	0.000356	0.00236	CbGeAlD
Imatinib—Syncope—Naltrexone—alcohol dependence	0.000355	0.00128	CcSEcCtD
Imatinib—Anxiety—Acamprosate—alcohol dependence	0.000355	0.00128	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000354	0.00127	CcSEcCtD
Imatinib—CA2—cardiovascular system—alcohol dependence	0.000353	0.00235	CbGeAlD
Imatinib—Pancreatitis—Citalopram—alcohol dependence	0.000353	0.00127	CcSEcCtD
Imatinib—Discomfort—Acamprosate—alcohol dependence	0.000352	0.00126	CcSEcCtD
Imatinib—PDGFRB—cerebellum—alcohol dependence	0.000352	0.00234	CbGeAlD
Imatinib—Angina pectoris—Citalopram—alcohol dependence	0.000351	0.00126	CcSEcCtD
Imatinib—Sweating increased—Citalopram—alcohol dependence	0.000351	0.00126	CcSEcCtD
Imatinib—ORM1—nervous system—alcohol dependence	0.00035	0.00233	CbGeAlD
Imatinib—Palpitations—Naltrexone—alcohol dependence	0.00035	0.00126	CcSEcCtD
Imatinib—CA1—nervous system—alcohol dependence	0.00035	0.00232	CbGeAlD
Imatinib—Dry mouth—Acamprosate—alcohol dependence	0.000348	0.00125	CcSEcCtD
Imatinib—Loss of consciousness—Naltrexone—alcohol dependence	0.000348	0.00125	CcSEcCtD
Imatinib—Cough—Naltrexone—alcohol dependence	0.000346	0.00124	CcSEcCtD
Imatinib—Confusional state—Acamprosate—alcohol dependence	0.000344	0.00124	CcSEcCtD
Imatinib—CA2—pancreas—alcohol dependence	0.000343	0.00228	CbGeAlD
Imatinib—Convulsion—Naltrexone—alcohol dependence	0.000343	0.00123	CcSEcCtD
Imatinib—SLC22A1—endocrine gland—alcohol dependence	0.000343	0.00228	CbGeAlD
Imatinib—Pancytopenia—Citalopram—alcohol dependence	0.000342	0.00123	CcSEcCtD
Imatinib—Hypertension—Naltrexone—alcohol dependence	0.000342	0.00123	CcSEcCtD
Imatinib—Anaphylactic shock—Acamprosate—alcohol dependence	0.000342	0.00123	CcSEcCtD
Imatinib—Infection—Acamprosate—alcohol dependence	0.000339	0.00122	CcSEcCtD
Imatinib—ABL1—testis—alcohol dependence	0.000339	0.00225	CbGeAlD
Imatinib—ORM1—liver—alcohol dependence	0.000338	0.00224	CbGeAlD
Imatinib—CA12—brain—alcohol dependence	0.000338	0.00224	CbGeAlD
Imatinib—ORM1—central nervous system—alcohol dependence	0.000337	0.00224	CbGeAlD
Imatinib—Chest pain—Naltrexone—alcohol dependence	0.000337	0.00121	CcSEcCtD
Imatinib—Arthralgia—Naltrexone—alcohol dependence	0.000337	0.00121	CcSEcCtD
Imatinib—Myalgia—Naltrexone—alcohol dependence	0.000337	0.00121	CcSEcCtD
Imatinib—CA1—liver—alcohol dependence	0.000337	0.00224	CbGeAlD
Imatinib—CA1—central nervous system—alcohol dependence	0.000337	0.00224	CbGeAlD
Imatinib—Shock—Acamprosate—alcohol dependence	0.000336	0.00121	CcSEcCtD
Imatinib—Anxiety—Naltrexone—alcohol dependence	0.000336	0.00121	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000335	0.0012	CcSEcCtD
Imatinib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000335	0.0012	CcSEcCtD
Imatinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000334	0.0012	CcSEcCtD
Imatinib—Tachycardia—Acamprosate—alcohol dependence	0.000333	0.0012	CcSEcCtD
Imatinib—Discomfort—Naltrexone—alcohol dependence	0.000333	0.0012	CcSEcCtD
Imatinib—ABL1—nervous system—alcohol dependence	0.000333	0.00221	CbGeAlD
Imatinib—Pollakiuria—Citalopram—alcohol dependence	0.000333	0.00119	CcSEcCtD
Imatinib—Skin disorder—Acamprosate—alcohol dependence	0.000332	0.00119	CcSEcCtD
Imatinib—Erectile dysfunction—Citalopram—alcohol dependence	0.000332	0.00119	CcSEcCtD
Imatinib—Hyperhidrosis—Acamprosate—alcohol dependence	0.00033	0.00119	CcSEcCtD
Imatinib—Dry mouth—Naltrexone—alcohol dependence	0.00033	0.00118	CcSEcCtD
Imatinib—Photosensitivity reaction—Citalopram—alcohol dependence	0.000329	0.00118	CcSEcCtD
Imatinib—Weight increased—Citalopram—alcohol dependence	0.000328	0.00118	CcSEcCtD
Imatinib—Confusional state—Naltrexone—alcohol dependence	0.000326	0.00117	CcSEcCtD
Imatinib—Weight decreased—Citalopram—alcohol dependence	0.000326	0.00117	CcSEcCtD
Imatinib—Anorexia—Acamprosate—alcohol dependence	0.000326	0.00117	CcSEcCtD
Imatinib—Hyperglycaemia—Citalopram—alcohol dependence	0.000325	0.00117	CcSEcCtD
Imatinib—Anaphylactic shock—Naltrexone—alcohol dependence	0.000323	0.00116	CcSEcCtD
Imatinib—Oedema—Naltrexone—alcohol dependence	0.000323	0.00116	CcSEcCtD
Imatinib—Pneumonia—Citalopram—alcohol dependence	0.000323	0.00116	CcSEcCtD
Imatinib—PTGS1—forebrain—alcohol dependence	0.000323	0.00214	CbGeAlD
Imatinib—CSF1R—brain—alcohol dependence	0.000322	0.00214	CbGeAlD
Imatinib—Infection—Naltrexone—alcohol dependence	0.000321	0.00115	CcSEcCtD
Imatinib—Infestation—Citalopram—alcohol dependence	0.000321	0.00115	CcSEcCtD
Imatinib—Infestation NOS—Citalopram—alcohol dependence	0.000321	0.00115	CcSEcCtD
Imatinib—SLC22A1—nervous system—alcohol dependence	0.000321	0.00213	CbGeAlD
Imatinib—ABL1—liver—alcohol dependence	0.000321	0.00213	CbGeAlD
Imatinib—ABL1—central nervous system—alcohol dependence	0.000321	0.00213	CbGeAlD
Imatinib—Depression—Citalopram—alcohol dependence	0.00032	0.00115	CcSEcCtD
Imatinib—CYP2C19—digestive system—alcohol dependence	0.00032	0.00213	CbGeAlD
Imatinib—Hypotension—Acamprosate—alcohol dependence	0.000319	0.00115	CcSEcCtD
Imatinib—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000318	0.00114	CcSEcCtD
Imatinib—Shock—Naltrexone—alcohol dependence	0.000318	0.00114	CcSEcCtD
Imatinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000317	0.00114	CcSEcCtD
Imatinib—Acute coronary syndrome—Citalopram—alcohol dependence	0.000317	0.00114	CcSEcCtD
Imatinib—Tachycardia—Naltrexone—alcohol dependence	0.000315	0.00113	CcSEcCtD
Imatinib—Myocardial infarction—Citalopram—alcohol dependence	0.000315	0.00113	CcSEcCtD
Imatinib—Neuropathy peripheral—Citalopram—alcohol dependence	0.000315	0.00113	CcSEcCtD
Imatinib—Skin disorder—Naltrexone—alcohol dependence	0.000314	0.00113	CcSEcCtD
Imatinib—ABL1—cerebellum—alcohol dependence	0.000313	0.00208	CbGeAlD
Imatinib—ALB—testis—alcohol dependence	0.000313	0.00208	CbGeAlD
Imatinib—Jaundice—Citalopram—alcohol dependence	0.000313	0.00112	CcSEcCtD
Imatinib—Stomatitis—Citalopram—alcohol dependence	0.000313	0.00112	CcSEcCtD
Imatinib—Hyperhidrosis—Naltrexone—alcohol dependence	0.000312	0.00112	CcSEcCtD
Imatinib—Urinary tract infection—Citalopram—alcohol dependence	0.000312	0.00112	CcSEcCtD
Imatinib—Conjunctivitis—Citalopram—alcohol dependence	0.000312	0.00112	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000311	0.00112	CcSEcCtD
Imatinib—SLC22A1—liver—alcohol dependence	0.000309	0.00205	CbGeAlD
Imatinib—SLC22A1—central nervous system—alcohol dependence	0.000309	0.00205	CbGeAlD
Imatinib—Insomnia—Acamprosate—alcohol dependence	0.000309	0.00111	CcSEcCtD
Imatinib—Anorexia—Naltrexone—alcohol dependence	0.000308	0.00111	CcSEcCtD
Imatinib—Sweating—Citalopram—alcohol dependence	0.000308	0.00111	CcSEcCtD
Imatinib—Paraesthesia—Acamprosate—alcohol dependence	0.000307	0.0011	CcSEcCtD
Imatinib—Haematuria—Citalopram—alcohol dependence	0.000306	0.0011	CcSEcCtD
Imatinib—CYP2C19—blood—alcohol dependence	0.000305	0.00202	CbGeAlD
Imatinib—Dyspnoea—Acamprosate—alcohol dependence	0.000305	0.00109	CcSEcCtD
Imatinib—Somnolence—Acamprosate—alcohol dependence	0.000304	0.00109	CcSEcCtD
Imatinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000304	0.00109	CcSEcCtD
Imatinib—Epistaxis—Citalopram—alcohol dependence	0.000303	0.00109	CcSEcCtD
Imatinib—Sinusitis—Citalopram—alcohol dependence	0.000301	0.00108	CcSEcCtD
Imatinib—Dyspepsia—Acamprosate—alcohol dependence	0.000301	0.00108	CcSEcCtD
Imatinib—Agranulocytosis—Citalopram—alcohol dependence	0.0003	0.00108	CcSEcCtD
Imatinib—CYP2C9—cardiovascular system—alcohol dependence	0.000299	0.00198	CbGeAlD
Imatinib—Decreased appetite—Acamprosate—alcohol dependence	0.000297	0.00107	CcSEcCtD
Imatinib—ALB—liver—alcohol dependence	0.000296	0.00197	CbGeAlD
Imatinib—CYP3A5—pancreas—alcohol dependence	0.000295	0.00196	CbGeAlD
Imatinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000295	0.00106	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000294	0.00106	CcSEcCtD
Imatinib—SLC47A1—brain—alcohol dependence	0.000294	0.00195	CbGeAlD
Imatinib—CA2—digestive system—alcohol dependence	0.000293	0.00195	CbGeAlD
Imatinib—KIT—brain—alcohol dependence	0.000292	0.00194	CbGeAlD
Imatinib—Insomnia—Naltrexone—alcohol dependence	0.000292	0.00105	CcSEcCtD
Imatinib—Pain—Acamprosate—alcohol dependence	0.000292	0.00105	CcSEcCtD
Imatinib—Constipation—Acamprosate—alcohol dependence	0.000292	0.00105	CcSEcCtD
Imatinib—Paraesthesia—Naltrexone—alcohol dependence	0.00029	0.00104	CcSEcCtD
Imatinib—Haemoglobin—Citalopram—alcohol dependence	0.00029	0.00104	CcSEcCtD
Imatinib—Rhinitis—Citalopram—alcohol dependence	0.000289	0.00104	CcSEcCtD
Imatinib—Hepatitis—Citalopram—alcohol dependence	0.000288	0.00104	CcSEcCtD
Imatinib—Haemorrhage—Citalopram—alcohol dependence	0.000288	0.00104	CcSEcCtD
Imatinib—Dyspnoea—Naltrexone—alcohol dependence	0.000288	0.00103	CcSEcCtD
Imatinib—Somnolence—Naltrexone—alcohol dependence	0.000287	0.00103	CcSEcCtD
Imatinib—Hypoaesthesia—Citalopram—alcohol dependence	0.000287	0.00103	CcSEcCtD
Imatinib—Pharyngitis—Citalopram—alcohol dependence	0.000286	0.00103	CcSEcCtD
Imatinib—PDGFRB—brain—alcohol dependence	0.000286	0.0019	CbGeAlD
Imatinib—Urinary tract disorder—Citalopram—alcohol dependence	0.000285	0.00102	CcSEcCtD
Imatinib—Oedema peripheral—Citalopram—alcohol dependence	0.000284	0.00102	CcSEcCtD
Imatinib—Connective tissue disorder—Citalopram—alcohol dependence	0.000283	0.00102	CcSEcCtD
Imatinib—Urethral disorder—Citalopram—alcohol dependence	0.000283	0.00101	CcSEcCtD
Imatinib—Feeling abnormal—Acamprosate—alcohol dependence	0.000281	0.00101	CcSEcCtD
Imatinib—Decreased appetite—Naltrexone—alcohol dependence	0.000281	0.00101	CcSEcCtD
Imatinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000279	0.001	CcSEcCtD
Imatinib—CA2—blood—alcohol dependence	0.000279	0.00186	CbGeAlD
Imatinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000279	0.001	CcSEcCtD
Imatinib—Fatigue—Naltrexone—alcohol dependence	0.000279	0.001	CcSEcCtD
Imatinib—Constipation—Naltrexone—alcohol dependence	0.000276	0.000993	CcSEcCtD
Imatinib—Pain—Naltrexone—alcohol dependence	0.000276	0.000993	CcSEcCtD
Imatinib—CA2—midbrain—alcohol dependence	0.000276	0.00183	CbGeAlD
Imatinib—CYP2D6—brainstem—alcohol dependence	0.000275	0.00183	CbGeAlD
Imatinib—PTGS1—cardiovascular system—alcohol dependence	0.000273	0.00181	CbGeAlD
Imatinib—Erythema multiforme—Citalopram—alcohol dependence	0.000273	0.000979	CcSEcCtD
Imatinib—Urticaria—Acamprosate—alcohol dependence	0.000271	0.000975	CcSEcCtD
Imatinib—Body temperature increased—Acamprosate—alcohol dependence	0.00027	0.00097	CcSEcCtD
Imatinib—Abdominal pain—Acamprosate—alcohol dependence	0.00027	0.00097	CcSEcCtD
Imatinib—Eye disorder—Citalopram—alcohol dependence	0.000269	0.000967	CcSEcCtD
Imatinib—Tinnitus—Citalopram—alcohol dependence	0.000269	0.000965	CcSEcCtD
Imatinib—Cardiac disorder—Citalopram—alcohol dependence	0.000267	0.000961	CcSEcCtD
Imatinib—Flushing—Citalopram—alcohol dependence	0.000267	0.000961	CcSEcCtD
Imatinib—CA1—brain—alcohol dependence	0.000267	0.00178	CbGeAlD
Imatinib—Feeling abnormal—Naltrexone—alcohol dependence	0.000266	0.000957	CcSEcCtD
Imatinib—CYP2D6—forebrain—alcohol dependence	0.000265	0.00176	CbGeAlD
Imatinib—CYP2C19—endocrine gland—alcohol dependence	0.000264	0.00176	CbGeAlD
Imatinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000264	0.000949	CcSEcCtD
Imatinib—Angiopathy—Citalopram—alcohol dependence	0.000262	0.000939	CcSEcCtD
Imatinib—CYP1A2—digestive system—alcohol dependence	0.000261	0.00174	CbGeAlD
Imatinib—Immune system disorder—Citalopram—alcohol dependence	0.00026	0.000935	CcSEcCtD
Imatinib—Mediastinal disorder—Citalopram—alcohol dependence	0.00026	0.000933	CcSEcCtD
Imatinib—ABCG2—blood—alcohol dependence	0.000259	0.00172	CbGeAlD
Imatinib—Chills—Citalopram—alcohol dependence	0.000259	0.000929	CcSEcCtD
Imatinib—Arrhythmia—Citalopram—alcohol dependence	0.000257	0.000925	CcSEcCtD
Imatinib—Urticaria—Naltrexone—alcohol dependence	0.000257	0.000922	CcSEcCtD
Imatinib—Body temperature increased—Naltrexone—alcohol dependence	0.000255	0.000918	CcSEcCtD
Imatinib—Abdominal pain—Naltrexone—alcohol dependence	0.000255	0.000918	CcSEcCtD
Imatinib—ABCG2—midbrain—alcohol dependence	0.000255	0.0017	CbGeAlD
Imatinib—Alopecia—Citalopram—alcohol dependence	0.000255	0.000915	CcSEcCtD
Imatinib—ABL1—brain—alcohol dependence	0.000255	0.00169	CbGeAlD
Imatinib—Mental disorder—Citalopram—alcohol dependence	0.000253	0.000907	CcSEcCtD
Imatinib—CYP3A5—digestive system—alcohol dependence	0.000252	0.00167	CbGeAlD
Imatinib—Hypersensitivity—Acamprosate—alcohol dependence	0.000252	0.000904	CcSEcCtD
Imatinib—Malnutrition—Citalopram—alcohol dependence	0.000251	0.000901	CcSEcCtD
Imatinib—Erythema—Citalopram—alcohol dependence	0.000251	0.000901	CcSEcCtD
Imatinib—CYP1A2—blood—alcohol dependence	0.000249	0.00165	CbGeAlD
Imatinib—CYP2C9—digestive system—alcohol dependence	0.000248	0.00165	CbGeAlD
Imatinib—Flatulence—Citalopram—alcohol dependence	0.000247	0.000888	CcSEcCtD
Imatinib—Dysgeusia—Citalopram—alcohol dependence	0.000246	0.000883	CcSEcCtD
Imatinib—SLC22A1—brain—alcohol dependence	0.000245	0.00163	CbGeAlD
Imatinib—Asthenia—Acamprosate—alcohol dependence	0.000245	0.00088	CcSEcCtD
Imatinib—Back pain—Citalopram—alcohol dependence	0.000243	0.000872	CcSEcCtD
Imatinib—CA2—endocrine gland—alcohol dependence	0.000242	0.00161	CbGeAlD
Imatinib—Pruritus—Acamprosate—alcohol dependence	0.000242	0.000868	CcSEcCtD
Imatinib—Muscle spasms—Citalopram—alcohol dependence	0.000241	0.000866	CcSEcCtD
Imatinib—CYP3A5—blood—alcohol dependence	0.00024	0.00159	CbGeAlD
Imatinib—CYP2C19—liver—alcohol dependence	0.000238	0.00158	CbGeAlD
Imatinib—Hypersensitivity—Naltrexone—alcohol dependence	0.000238	0.000855	CcSEcCtD
Imatinib—Vision blurred—Citalopram—alcohol dependence	0.000236	0.000849	CcSEcCtD
Imatinib—CYP2C9—blood—alcohol dependence	0.000236	0.00157	CbGeAlD
Imatinib—Tremor—Citalopram—alcohol dependence	0.000235	0.000844	CcSEcCtD
Imatinib—ALB—brain—alcohol dependence	0.000235	0.00156	CbGeAlD
Imatinib—Diarrhoea—Acamprosate—alcohol dependence	0.000234	0.000839	CcSEcCtD
Imatinib—Ill-defined disorder—Citalopram—alcohol dependence	0.000233	0.000836	CcSEcCtD
Imatinib—Anaemia—Citalopram—alcohol dependence	0.000232	0.000833	CcSEcCtD
Imatinib—Asthenia—Naltrexone—alcohol dependence	0.000232	0.000833	CcSEcCtD
Imatinib—CA2—testis—alcohol dependence	0.000231	0.00153	CbGeAlD
Imatinib—Angioedema—Citalopram—alcohol dependence	0.000229	0.000823	CcSEcCtD
Imatinib—Pruritus—Naltrexone—alcohol dependence	0.000229	0.000821	CcSEcCtD
Imatinib—CA2—nervous system—alcohol dependence	0.000227	0.00151	CbGeAlD
Imatinib—PTGS1—digestive system—alcohol dependence	0.000226	0.0015	CbGeAlD
Imatinib—Malaise—Citalopram—alcohol dependence	0.000226	0.000813	CcSEcCtD
Imatinib—Dizziness—Acamprosate—alcohol dependence	0.000226	0.000811	CcSEcCtD
Imatinib—Vertigo—Citalopram—alcohol dependence	0.000225	0.00081	CcSEcCtD
Imatinib—Syncope—Citalopram—alcohol dependence	0.000225	0.000808	CcSEcCtD
Imatinib—Leukopenia—Citalopram—alcohol dependence	0.000225	0.000807	CcSEcCtD
Imatinib—Palpitations—Citalopram—alcohol dependence	0.000222	0.000796	CcSEcCtD
Imatinib—Diarrhoea—Naltrexone—alcohol dependence	0.000221	0.000794	CcSEcCtD
Imatinib—Loss of consciousness—Citalopram—alcohol dependence	0.000221	0.000792	CcSEcCtD
Imatinib—Cough—Citalopram—alcohol dependence	0.000219	0.000786	CcSEcCtD
Imatinib—CA2—liver—alcohol dependence	0.000218	0.00145	CbGeAlD
Imatinib—CA2—central nervous system—alcohol dependence	0.000218	0.00145	CbGeAlD
Imatinib—Convulsion—Citalopram—alcohol dependence	0.000217	0.000781	CcSEcCtD
Imatinib—Vomiting—Acamprosate—alcohol dependence	0.000217	0.00078	CcSEcCtD
Imatinib—Hypertension—Citalopram—alcohol dependence	0.000217	0.000778	CcSEcCtD
Imatinib—CYP1A2—endocrine gland—alcohol dependence	0.000216	0.00143	CbGeAlD
Imatinib—PTGS1—blood—alcohol dependence	0.000216	0.00143	CbGeAlD
Imatinib—Rash—Acamprosate—alcohol dependence	0.000215	0.000774	CcSEcCtD
Imatinib—Dermatitis—Acamprosate—alcohol dependence	0.000215	0.000773	CcSEcCtD
Imatinib—Headache—Acamprosate—alcohol dependence	0.000214	0.000769	CcSEcCtD
Imatinib—ABCG2—testis—alcohol dependence	0.000214	0.00142	CbGeAlD
Imatinib—Dizziness—Naltrexone—alcohol dependence	0.000214	0.000768	CcSEcCtD
Imatinib—Arthralgia—Citalopram—alcohol dependence	0.000214	0.000767	CcSEcCtD
Imatinib—Myalgia—Citalopram—alcohol dependence	0.000214	0.000767	CcSEcCtD
Imatinib—Chest pain—Citalopram—alcohol dependence	0.000214	0.000767	CcSEcCtD
Imatinib—CA2—cerebellum—alcohol dependence	0.000213	0.00142	CbGeAlD
Imatinib—Anxiety—Citalopram—alcohol dependence	0.000213	0.000765	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000212	0.000762	CcSEcCtD
Imatinib—Discomfort—Citalopram—alcohol dependence	0.000211	0.000758	CcSEcCtD
Imatinib—Dry mouth—Citalopram—alcohol dependence	0.000209	0.00075	CcSEcCtD
Imatinib—CYP3A5—endocrine gland—alcohol dependence	0.000208	0.00138	CbGeAlD
Imatinib—Confusional state—Citalopram—alcohol dependence	0.000206	0.000742	CcSEcCtD
Imatinib—Vomiting—Naltrexone—alcohol dependence	0.000205	0.000738	CcSEcCtD
Imatinib—CYP2C9—endocrine gland—alcohol dependence	0.000205	0.00136	CbGeAlD
Imatinib—Anaphylactic shock—Citalopram—alcohol dependence	0.000205	0.000736	CcSEcCtD
Imatinib—Oedema—Citalopram—alcohol dependence	0.000205	0.000736	CcSEcCtD
Imatinib—Rash—Naltrexone—alcohol dependence	0.000204	0.000732	CcSEcCtD
Imatinib—Dermatitis—Naltrexone—alcohol dependence	0.000204	0.000731	CcSEcCtD
Imatinib—Infection—Citalopram—alcohol dependence	0.000203	0.000731	CcSEcCtD
Imatinib—Nausea—Acamprosate—alcohol dependence	0.000203	0.000729	CcSEcCtD
Imatinib—Headache—Naltrexone—alcohol dependence	0.000202	0.000727	CcSEcCtD
Imatinib—ABCG2—liver—alcohol dependence	0.000202	0.00134	CbGeAlD
Imatinib—Shock—Citalopram—alcohol dependence	0.000201	0.000724	CcSEcCtD
Imatinib—Nervous system disorder—Citalopram—alcohol dependence	0.000201	0.000721	CcSEcCtD
Imatinib—Thrombocytopenia—Citalopram—alcohol dependence	0.0002	0.00072	CcSEcCtD
Imatinib—Tachycardia—Citalopram—alcohol dependence	0.0002	0.000718	CcSEcCtD
Imatinib—Skin disorder—Citalopram—alcohol dependence	0.000199	0.000714	CcSEcCtD
Imatinib—Hyperhidrosis—Citalopram—alcohol dependence	0.000198	0.000711	CcSEcCtD
Imatinib—ABCG2—cerebellum—alcohol dependence	0.000198	0.00131	CbGeAlD
Imatinib—Anorexia—Citalopram—alcohol dependence	0.000195	0.000701	CcSEcCtD
Imatinib—CYP1A2—liver—alcohol dependence	0.000195	0.00129	CbGeAlD
Imatinib—Nausea—Naltrexone—alcohol dependence	0.000192	0.00069	CcSEcCtD
Imatinib—Hypotension—Citalopram—alcohol dependence	0.000191	0.000687	CcSEcCtD
Imatinib—ABCB1—forebrain—alcohol dependence	0.000191	0.00127	CbGeAlD
Imatinib—CYP3A4—digestive system—alcohol dependence	0.000189	0.00126	CbGeAlD
Imatinib—CYP3A5—liver—alcohol dependence	0.000188	0.00125	CbGeAlD
Imatinib—PTGS1—endocrine gland—alcohol dependence	0.000187	0.00124	CbGeAlD
Imatinib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000187	0.00067	CcSEcCtD
Imatinib—CYP2D6—digestive system—alcohol dependence	0.000186	0.00124	CbGeAlD
Imatinib—Insomnia—Citalopram—alcohol dependence	0.000185	0.000665	CcSEcCtD
Imatinib—CYP2C9—liver—alcohol dependence	0.000185	0.00123	CbGeAlD
Imatinib—Paraesthesia—Citalopram—alcohol dependence	0.000184	0.00066	CcSEcCtD
Imatinib—Dyspnoea—Citalopram—alcohol dependence	0.000183	0.000656	CcSEcCtD
Imatinib—Somnolence—Citalopram—alcohol dependence	0.000182	0.000654	CcSEcCtD
Imatinib—Dyspepsia—Citalopram—alcohol dependence	0.00018	0.000647	CcSEcCtD
Imatinib—CYP3A4—blood—alcohol dependence	0.00018	0.0012	CbGeAlD
Imatinib—PTGS1—testis—alcohol dependence	0.000178	0.00119	CbGeAlD
Imatinib—Decreased appetite—Citalopram—alcohol dependence	0.000178	0.000639	CcSEcCtD
Imatinib—CYP2D6—blood—alcohol dependence	0.000177	0.00118	CbGeAlD
Imatinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000177	0.000635	CcSEcCtD
Imatinib—ABCB1—adrenal cortex—alcohol dependence	0.000177	0.00117	CbGeAlD
Imatinib—Fatigue—Citalopram—alcohol dependence	0.000177	0.000634	CcSEcCtD
Imatinib—PTGS1—nervous system—alcohol dependence	0.000175	0.00116	CbGeAlD
Imatinib—Pain—Citalopram—alcohol dependence	0.000175	0.000629	CcSEcCtD
Imatinib—Constipation—Citalopram—alcohol dependence	0.000175	0.000629	CcSEcCtD
Imatinib—CA2—brain—alcohol dependence	0.000173	0.00115	CbGeAlD
Imatinib—Feeling abnormal—Citalopram—alcohol dependence	0.000169	0.000606	CcSEcCtD
Imatinib—PTGS1—central nervous system—alcohol dependence	0.000169	0.00112	CbGeAlD
Imatinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000167	0.000601	CcSEcCtD
Imatinib—Urticaria—Citalopram—alcohol dependence	0.000163	0.000584	CcSEcCtD
Imatinib—Body temperature increased—Citalopram—alcohol dependence	0.000162	0.000581	CcSEcCtD
Imatinib—Abdominal pain—Citalopram—alcohol dependence	0.000162	0.000581	CcSEcCtD
Imatinib—ABCB1—cardiovascular system—alcohol dependence	0.000161	0.00107	CbGeAlD
Imatinib—ABCG2—brain—alcohol dependence	0.000161	0.00107	CbGeAlD
Imatinib—ABCB1—pancreas—alcohol dependence	0.000157	0.00104	CbGeAlD
Imatinib—CYP3A4—endocrine gland—alcohol dependence	0.000156	0.00104	CbGeAlD
Imatinib—CYP2D6—endocrine gland—alcohol dependence	0.000154	0.00102	CbGeAlD
Imatinib—Hypersensitivity—Citalopram—alcohol dependence	0.000151	0.000542	CcSEcCtD
Imatinib—Asthenia—Citalopram—alcohol dependence	0.000147	0.000528	CcSEcCtD
Imatinib—CYP2D6—testis—alcohol dependence	0.000147	0.000974	CbGeAlD
Imatinib—ABCB1—gonad—alcohol dependence	0.000146	0.000972	CbGeAlD
Imatinib—CYP3A4—nervous system—alcohol dependence	0.000146	0.000972	CbGeAlD
Imatinib—Pruritus—Citalopram—alcohol dependence	0.000145	0.00052	CcSEcCtD
Imatinib—CYP2D6—nervous system—alcohol dependence	0.000144	0.000956	CbGeAlD
Imatinib—CYP3A4—liver—alcohol dependence	0.000141	0.000936	CbGeAlD
Imatinib—CYP3A4—central nervous system—alcohol dependence	0.000141	0.000936	CbGeAlD
Imatinib—Diarrhoea—Citalopram—alcohol dependence	0.00014	0.000503	CcSEcCtD
Imatinib—CYP2D6—liver—alcohol dependence	0.000139	0.000921	CbGeAlD
Imatinib—CYP2D6—central nervous system—alcohol dependence	0.000139	0.000921	CbGeAlD
Imatinib—CYP2D6—cerebellum—alcohol dependence	0.000135	0.0009	CbGeAlD
Imatinib—Dizziness—Citalopram—alcohol dependence	0.000135	0.000486	CcSEcCtD
Imatinib—ABCB1—digestive system—alcohol dependence	0.000134	0.000889	CbGeAlD
Imatinib—PTGS1—brain—alcohol dependence	0.000134	0.000889	CbGeAlD
Imatinib—Vomiting—Citalopram—alcohol dependence	0.00013	0.000468	CcSEcCtD
Imatinib—Rash—Citalopram—alcohol dependence	0.000129	0.000464	CcSEcCtD
Imatinib—Dermatitis—Citalopram—alcohol dependence	0.000129	0.000463	CcSEcCtD
Imatinib—Headache—Citalopram—alcohol dependence	0.000128	0.000461	CcSEcCtD
Imatinib—ABCB1—blood—alcohol dependence	0.000128	0.000847	CbGeAlD
Imatinib—ABCB1—midbrain—alcohol dependence	0.000126	0.000837	CbGeAlD
Imatinib—Nausea—Citalopram—alcohol dependence	0.000122	0.000437	CcSEcCtD
Imatinib—ABCB1—endocrine gland—alcohol dependence	0.000111	0.000735	CbGeAlD
Imatinib—CYP2D6—brain—alcohol dependence	0.00011	0.000731	CbGeAlD
Imatinib—ABCB1—testis—alcohol dependence	0.000106	0.000701	CbGeAlD
Imatinib—ABCB1—nervous system—alcohol dependence	0.000104	0.000688	CbGeAlD
Imatinib—ABCB1—liver—alcohol dependence	9.97e-05	0.000663	CbGeAlD
Imatinib—ABCB1—central nervous system—alcohol dependence	9.97e-05	0.000662	CbGeAlD
Imatinib—ABCB1—cerebellum—alcohol dependence	9.74e-05	0.000647	CbGeAlD
Imatinib—ABCB1—brain—alcohol dependence	7.91e-05	0.000526	CbGeAlD
Imatinib—PDGFRB—Signaling Pathways—OPRM1—alcohol dependence	2.74e-05	0.000204	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PDYN—alcohol dependence	2.74e-05	0.000204	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADH1A—alcohol dependence	2.72e-05	0.000202	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MAOB—alcohol dependence	2.72e-05	0.000202	CbGpPWpGaD
Imatinib—PDGFRB—Disease—GOT1—alcohol dependence	2.71e-05	0.000202	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR1B—alcohol dependence	2.7e-05	0.000201	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CRH—alcohol dependence	2.7e-05	0.000201	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GGT2—alcohol dependence	2.67e-05	0.000199	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AVP—alcohol dependence	2.67e-05	0.000198	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MAOB—alcohol dependence	2.61e-05	0.000194	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—POMC—alcohol dependence	2.6e-05	0.000193	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—WASF2—alcohol dependence	2.55e-05	0.000189	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CRHR1—alcohol dependence	2.55e-05	0.000189	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADH4—alcohol dependence	2.54e-05	0.000189	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NPY—alcohol dependence	2.52e-05	0.000187	CbGpPWpGaD
Imatinib—LCK—Disease—GOT2—alcohol dependence	2.52e-05	0.000187	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DRD4—alcohol dependence	2.49e-05	0.000185	CbGpPWpGaD
Imatinib—CA14—Metabolism—EP300—alcohol dependence	2.49e-05	0.000185	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADH4—alcohol dependence	2.48e-05	0.000184	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.47e-05	0.000184	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.45e-05	0.000182	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ADH1B—alcohol dependence	2.45e-05	0.000182	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—WASF1—alcohol dependence	2.44e-05	0.000182	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR1B—alcohol dependence	2.43e-05	0.000181	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CRH—alcohol dependence	2.43e-05	0.000181	CbGpPWpGaD
Imatinib—CA6—Metabolism—EP300—alcohol dependence	2.43e-05	0.00018	CbGpPWpGaD
Imatinib—CA2—Metabolism—POMC—alcohol dependence	2.42e-05	0.00018	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALDH2—alcohol dependence	2.4e-05	0.000179	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADH7—alcohol dependence	2.4e-05	0.000179	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CHRM2—alcohol dependence	2.39e-05	0.000178	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALDH2—alcohol dependence	2.38e-05	0.000177	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CNR1—alcohol dependence	2.38e-05	0.000177	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALDH2—alcohol dependence	2.38e-05	0.000177	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD4—alcohol dependence	2.36e-05	0.000175	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADH4—alcohol dependence	2.33e-05	0.000173	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADH1A—alcohol dependence	2.32e-05	0.000173	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DRD2—alcohol dependence	2.32e-05	0.000173	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR7—alcohol dependence	2.32e-05	0.000173	CbGpPWpGaD
Imatinib—CA1—Metabolism—POMC—alcohol dependence	2.32e-05	0.000172	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADH4—alcohol dependence	2.31e-05	0.000172	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALDH2—alcohol dependence	2.31e-05	0.000172	CbGpPWpGaD
Imatinib—ALB—Metabolism—GGT2—alcohol dependence	2.3e-05	0.000171	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—EP300—alcohol dependence	2.29e-05	0.00017	CbGpPWpGaD
Imatinib—CA7—Metabolism—EP300—alcohol dependence	2.26e-05	0.000168	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CNR1—alcohol dependence	2.25e-05	0.000168	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.22e-05	0.000165	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR2A—alcohol dependence	2.22e-05	0.000165	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALDH2—alcohol dependence	2.22e-05	0.000165	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR7—alcohol dependence	2.2e-05	0.000163	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD2—alcohol dependence	2.2e-05	0.000163	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—OPRM1—alcohol dependence	2.2e-05	0.000163	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.2e-05	0.000163	CbGpPWpGaD
Imatinib—LCK—Disease—GOT1—alcohol dependence	2.18e-05	0.000162	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—EP300—alcohol dependence	2.17e-05	0.000161	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH6—alcohol dependence	2.16e-05	0.000161	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.16e-05	0.000161	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADH7—alcohol dependence	2.16e-05	0.00016	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—EP300—alcohol dependence	2.15e-05	0.00016	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD4—alcohol dependence	2.13e-05	0.000158	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—EP300—alcohol dependence	2.11e-05	0.000157	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADH1B—alcohol dependence	2.11e-05	0.000157	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADH7—alcohol dependence	2.1e-05	0.000156	CbGpPWpGaD
Imatinib—CA12—Metabolism—EP300—alcohol dependence	2.1e-05	0.000156	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GGT2—alcohol dependence	2.07e-05	0.000154	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GOT2—alcohol dependence	2.04e-05	0.000152	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	2.04e-05	0.000152	CbGpPWpGaD
Imatinib—CA9—Metabolism—POMC—alcohol dependence	2.04e-05	0.000151	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CNR1—alcohol dependence	2.03e-05	0.000151	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GOT2—alcohol dependence	2.03e-05	0.000151	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MAOB—alcohol dependence	2.03e-05	0.000151	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GOT2—alcohol dependence	2.02e-05	0.00015	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NPY—alcohol dependence	2.02e-05	0.00015	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GGT2—alcohol dependence	2.02e-05	0.00015	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.01e-05	0.000149	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2e-05	0.000149	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	1.99e-05	0.000148	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADH7—alcohol dependence	1.98e-05	0.000147	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR7—alcohol dependence	1.98e-05	0.000147	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD2—alcohol dependence	1.98e-05	0.000147	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADH4—alcohol dependence	1.98e-05	0.000147	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADH7—alcohol dependence	1.97e-05	0.000146	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GOT2—alcohol dependence	1.96e-05	0.000146	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AVP—alcohol dependence	1.95e-05	0.000145	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR1B—alcohol dependence	1.95e-05	0.000145	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CRH—alcohol dependence	1.95e-05	0.000145	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—EP300—alcohol dependence	1.95e-05	0.000145	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CYP2E1—alcohol dependence	1.92e-05	0.000143	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CYP2E1—alcohol dependence	1.91e-05	0.000142	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CYP2E1—alcohol dependence	1.9e-05	0.000141	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—EP300—alcohol dependence	1.9e-05	0.000141	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGT2—alcohol dependence	1.9e-05	0.000141	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADH1B—alcohol dependence	1.89e-05	0.000141	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT2—alcohol dependence	1.89e-05	0.00014	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGT2—alcohol dependence	1.89e-05	0.00014	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AVP—alcohol dependence	1.85e-05	0.000138	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CYP2E1—alcohol dependence	1.85e-05	0.000137	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADH1B—alcohol dependence	1.85e-05	0.000137	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.79e-05	0.000133	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.79e-05	0.000133	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CYP2E1—alcohol dependence	1.77e-05	0.000132	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—POMC—alcohol dependence	1.77e-05	0.000132	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GGT1—alcohol dependence	1.77e-05	0.000131	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GOT1—alcohol dependence	1.77e-05	0.000131	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GGT1—alcohol dependence	1.75e-05	0.00013	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GOT1—alcohol dependence	1.75e-05	0.00013	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GGT1—alcohol dependence	1.75e-05	0.00013	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GOT1—alcohol dependence	1.75e-05	0.00013	CbGpPWpGaD
Imatinib—ALB—Metabolism—MAOB—alcohol dependence	1.75e-05	0.00013	CbGpPWpGaD
Imatinib—LCK—Hemostasis—EP300—alcohol dependence	1.74e-05	0.000129	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.74e-05	0.000129	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADH1B—alcohol dependence	1.72e-05	0.000128	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALDH2—alcohol dependence	1.72e-05	0.000128	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.71e-05	0.000127	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD4—alcohol dependence	1.71e-05	0.000127	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GOT1—alcohol dependence	1.7e-05	0.000126	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GGT1—alcohol dependence	1.7e-05	0.000126	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADH7—alcohol dependence	1.68e-05	0.000125	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AVP—alcohol dependence	1.67e-05	0.000124	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CNR1—alcohol dependence	1.63e-05	0.000121	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT1—alcohol dependence	1.63e-05	0.000121	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GGT1—alcohol dependence	1.63e-05	0.000121	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR2A—alcohol dependence	1.63e-05	0.000121	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT2—alcohol dependence	1.61e-05	0.00012	CbGpPWpGaD
Imatinib—CA2—Metabolism—EP300—alcohol dependence	1.6e-05	0.000119	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD2—alcohol dependence	1.59e-05	0.000118	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR7—alcohol dependence	1.59e-05	0.000118	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MAOA—alcohol dependence	1.58e-05	0.000118	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MAOA—alcohol dependence	1.57e-05	0.000117	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MAOB—alcohol dependence	1.57e-05	0.000116	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—EP300—alcohol dependence	1.57e-05	0.000116	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MAOA—alcohol dependence	1.57e-05	0.000116	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR2A—alcohol dependence	1.54e-05	0.000114	CbGpPWpGaD
Imatinib—CA1—Metabolism—EP300—alcohol dependence	1.54e-05	0.000114	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MAOB—alcohol dependence	1.53e-05	0.000114	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH4—alcohol dependence	1.53e-05	0.000113	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MAOA—alcohol dependence	1.52e-05	0.000113	CbGpPWpGaD
Imatinib—ALB—Metabolism—ALDH2—alcohol dependence	1.48e-05	0.00011	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.47e-05	0.00011	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADH1B—alcohol dependence	1.47e-05	0.00011	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT2—alcohol dependence	1.47e-05	0.000109	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MAOA—alcohol dependence	1.46e-05	0.000108	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MAOB—alcohol dependence	1.44e-05	0.000107	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MAOB—alcohol dependence	1.43e-05	0.000106	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.43e-05	0.000106	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2A—alcohol dependence	1.39e-05	0.000103	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP2E1—alcohol dependence	1.38e-05	0.000102	CbGpPWpGaD
Imatinib—CA9—Metabolism—EP300—alcohol dependence	1.35e-05	0.0001	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AVP—alcohol dependence	1.34e-05	9.94e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—EP300—alcohol dependence	1.33e-05	9.91e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALDH2—alcohol dependence	1.33e-05	9.9e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.3e-05	9.67e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—POMC—alcohol dependence	1.3e-05	9.66e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.3e-05	9.64e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.28e-05	9.52e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT1—alcohol dependence	1.26e-05	9.4e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GGT1—alcohol dependence	1.26e-05	9.4e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT2—alcohol dependence	1.26e-05	9.38e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EP300—alcohol dependence	1.26e-05	9.38e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.24e-05	9.24e-05	CbGpPWpGaD
Imatinib—KIT—Disease—EP300—alcohol dependence	1.23e-05	9.15e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—POMC—alcohol dependence	1.23e-05	9.14e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.23e-05	9.11e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MAOB—alcohol dependence	1.22e-05	9.08e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALDH2—alcohol dependence	1.21e-05	9.03e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP2E1—alcohol dependence	1.19e-05	8.82e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EP300—alcohol dependence	1.18e-05	8.74e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.17e-05	8.68e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EP300—alcohol dependence	1.16e-05	8.66e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.14e-05	8.45e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EP300—alcohol dependence	1.14e-05	8.45e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MAOA—alcohol dependence	1.13e-05	8.43e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT2—alcohol dependence	1.13e-05	8.42e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2A—alcohol dependence	1.11e-05	8.27e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—POMC—alcohol dependence	1.11e-05	8.24e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—EP300—alcohol dependence	1.11e-05	8.23e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT2—alcohol dependence	1.11e-05	8.22e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GGT1—alcohol dependence	1.09e-05	8.1e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT1—alcohol dependence	1.09e-05	8.1e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP2E1—alcohol dependence	1.06e-05	7.92e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EP300—alcohol dependence	1.05e-05	7.8e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT2—alcohol dependence	1.04e-05	7.75e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—EP300—alcohol dependence	1.04e-05	7.73e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.04e-05	7.73e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALDH2—alcohol dependence	1.04e-05	7.72e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT2—alcohol dependence	1.03e-05	7.68e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—POMC—alcohol dependence	1.03e-05	7.66e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—POMC—alcohol dependence	1.02e-05	7.59e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—POMC—alcohol dependence	1.02e-05	7.58e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	9.98e-06	7.42e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—POMC—alcohol dependence	9.89e-06	7.36e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP2E1—alcohol dependence	9.8e-06	7.28e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GGT1—alcohol dependence	9.78e-06	7.27e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT1—alcohol dependence	9.78e-06	7.27e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MAOA—alcohol dependence	9.76e-06	7.26e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP2E1—alcohol dependence	9.71e-06	7.22e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT1—alcohol dependence	9.54e-06	7.1e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GGT1—alcohol dependence	9.54e-06	7.1e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—POMC—alcohol dependence	9.5e-06	7.06e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.47e-06	7.04e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MAOB—alcohol dependence	9.42e-06	7e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—EP300—alcohol dependence	9.12e-06	6.78e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGT1—alcohol dependence	8.99e-06	6.69e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT1—alcohol dependence	8.99e-06	6.69e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT1—alcohol dependence	8.92e-06	6.63e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGT1—alcohol dependence	8.92e-06	6.63e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—POMC—alcohol dependence	8.89e-06	6.61e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT2—alcohol dependence	8.83e-06	6.56e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MAOA—alcohol dependence	8.76e-06	6.51e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EP300—alcohol dependence	8.62e-06	6.41e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MAOA—alcohol dependence	8.55e-06	6.36e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	8.5e-06	6.32e-05	CbGpPWpGaD
Imatinib—LCK—Disease—EP300—alcohol dependence	8.42e-06	6.26e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP2E1—alcohol dependence	8.3e-06	6.17e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EP300—alcohol dependence	8.16e-06	6.06e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MAOA—alcohol dependence	8.06e-06	5.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	8.01e-06	5.96e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MAOA—alcohol dependence	7.99e-06	5.94e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.75e-06	5.76e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT1—alcohol dependence	7.62e-06	5.66e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT1—alcohol dependence	7.62e-06	5.66e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—POMC—alcohol dependence	7.38e-06	5.49e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EP300—alcohol dependence	7.35e-06	5.46e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—EP300—alcohol dependence	6.83e-06	5.08e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MAOA—alcohol dependence	6.83e-06	5.08e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT2—alcohol dependence	6.81e-06	5.06e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—EP300—alcohol dependence	6.77e-06	5.03e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—EP300—alcohol dependence	6.76e-06	5.03e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.62e-06	4.92e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—EP300—alcohol dependence	6.56e-06	4.88e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	6.4e-06	4.76e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—POMC—alcohol dependence	6.35e-06	4.72e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—EP300—alcohol dependence	6.3e-06	4.69e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EP300—alcohol dependence	5.9e-06	4.38e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT1—alcohol dependence	5.88e-06	4.37e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT1—alcohol dependence	5.88e-06	4.37e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—POMC—alcohol dependence	5.7e-06	4.24e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—POMC—alcohol dependence	5.57e-06	4.14e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MAOA—alcohol dependence	5.27e-06	3.92e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—POMC—alcohol dependence	5.25e-06	3.9e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—POMC—alcohol dependence	5.2e-06	3.87e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—EP300—alcohol dependence	4.89e-06	3.64e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—POMC—alcohol dependence	4.45e-06	3.3e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—EP300—alcohol dependence	4.22e-06	3.13e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—EP300—alcohol dependence	3.78e-06	2.81e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—EP300—alcohol dependence	3.69e-06	2.75e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—EP300—alcohol dependence	3.48e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—EP300—alcohol dependence	3.45e-06	2.57e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—POMC—alcohol dependence	3.43e-06	2.55e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—EP300—alcohol dependence	2.95e-06	2.19e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—EP300—alcohol dependence	2.28e-06	1.69e-05	CbGpPWpGaD
